IL195633A0 - Pyrrolidine derivatives having activity at the glyt1 transporter - Google Patents

Pyrrolidine derivatives having activity at the glyt1 transporter

Info

Publication number
IL195633A0
IL195633A0 IL195633A IL19563308A IL195633A0 IL 195633 A0 IL195633 A0 IL 195633A0 IL 195633 A IL195633 A IL 195633A IL 19563308 A IL19563308 A IL 19563308A IL 195633 A0 IL195633 A0 IL 195633A0
Authority
IL
Israel
Prior art keywords
activity
pyrrolidine derivatives
glyt1 transporter
glyt1
transporter
Prior art date
Application number
IL195633A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL195633A0 publication Critical patent/IL195633A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL195633A 2006-06-22 2008-12-01 Pyrrolidine derivatives having activity at the glyt1 transporter IL195633A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0612420.0A GB0612420D0 (en) 2006-06-22 2006-06-22 Compounds
PCT/EP2007/056106 WO2007147831A1 (en) 2006-06-22 2007-06-20 Pyrrolidine derivatives having activity at the glyt1 transporter

Publications (1)

Publication Number Publication Date
IL195633A0 true IL195633A0 (en) 2009-09-01

Family

ID=36803732

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195633A IL195633A0 (en) 2006-06-22 2008-12-01 Pyrrolidine derivatives having activity at the glyt1 transporter

Country Status (23)

Country Link
US (1) US20080070973A1 (OSRAM)
EP (1) EP2041082B1 (OSRAM)
JP (1) JP2009541261A (OSRAM)
KR (1) KR20090019847A (OSRAM)
CN (1) CN101506156A (OSRAM)
AR (1) AR061554A1 (OSRAM)
AT (1) ATE444288T1 (OSRAM)
AU (1) AU2007263058A1 (OSRAM)
BR (1) BRPI0713311A2 (OSRAM)
CA (1) CA2655399A1 (OSRAM)
CL (1) CL2007001808A1 (OSRAM)
CR (1) CR10498A (OSRAM)
DE (1) DE602007002642D1 (OSRAM)
EA (1) EA200970044A1 (OSRAM)
ES (1) ES2333918T3 (OSRAM)
GB (1) GB0612420D0 (OSRAM)
IL (1) IL195633A0 (OSRAM)
MA (1) MA30522B1 (OSRAM)
NO (1) NO20085412L (OSRAM)
PE (1) PE20080380A1 (OSRAM)
TW (1) TW200817322A (OSRAM)
WO (1) WO2007147831A1 (OSRAM)
ZA (1) ZA200810009B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
WO2008155334A2 (en) * 2007-06-20 2008-12-24 Glaxo Group Limited Improved process of amide formation
SG186885A1 (en) 2010-06-04 2013-02-28 Albany Molecular Res Inc Glycine transporter-1 inhibitors, methods of making them, and uses thereof
US20120035156A1 (en) * 2010-08-09 2012-02-09 Daniela Alberati Combination of glyt1 compound with antipsychotics
WO2019073052A1 (en) 2017-10-13 2019-04-18 Treeway Tw001 B.V. EDARAVONE SALT

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746959A (en) * 1953-06-02 1956-05-22 American Home Prod Diphenylethylenediamine-penicillin salt
US3145209A (en) * 1961-07-31 1964-08-18 Olin Mathieson Substituted aminophenyl-ethylamine derivatives
NZ237443A (en) * 1990-04-10 1993-11-25 Asta Medica Ag Phenalkylethylenediamine and aminomethyltetra hydroisoquinoline derivatives, platinum (ii) and (iv) complexes, methods of preparation and pharmaceutical compositions
GB0130696D0 (en) * 2001-12-21 2002-02-06 Smithkline Beecham Plc Chemical Compounds
FR2861070B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
PE20061156A1 (es) * 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina

Also Published As

Publication number Publication date
US20080070973A1 (en) 2008-03-20
BRPI0713311A2 (pt) 2012-03-06
GB0612420D0 (en) 2006-08-02
AU2007263058A1 (en) 2007-12-27
AR061554A1 (es) 2008-09-03
DE602007002642D1 (de) 2009-11-12
ES2333918T3 (es) 2010-03-02
NO20085412L (no) 2009-01-22
ZA200810009B (en) 2009-11-25
CL2007001808A1 (es) 2008-01-18
CA2655399A1 (en) 2007-12-27
EP2041082A1 (en) 2009-04-01
WO2007147831A1 (en) 2007-12-27
MA30522B1 (fr) 2009-06-01
EA200970044A1 (ru) 2009-04-28
TW200817322A (en) 2008-04-16
EP2041082B1 (en) 2009-09-30
ATE444288T1 (de) 2009-10-15
JP2009541261A (ja) 2009-11-26
CR10498A (es) 2009-03-20
KR20090019847A (ko) 2009-02-25
PE20080380A1 (es) 2008-05-31
CN101506156A (zh) 2009-08-12

Similar Documents

Publication Publication Date Title
EP1878727A4 (en) 2-AMINOQUINAZOLINE DERIVATIVES
IL185674A0 (en) 1-benzylindole-2-carboxamide derivatives
ZA200805411B (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
HUS2000022I1 (hu) Tiglien-3-on származékok
EP1942105A4 (en) AMINODIHYDROTHIAZINE DERIVATIVE
MX2008007823A (en) Merocyanine derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
ZA200804257B (en) Azaindole-2-carboxamide derivatives
EP1940843A4 (en) UNSATURATED HETEROCYCLIC DERIVATIVES
IL184841A0 (en) Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
IL192235A0 (en) Aryl-isoxazol-4-yl-imidazole derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
GB2424126B (en) Unit arrangement
PL1954674T3 (pl) Nowe pochodne N-fenetylokarboksyamidu
IL191138A0 (en) Pyrazoloisoquinoline derivatives
IL186107A0 (en) Pyridylmethylsulfone derivative
IL195633A0 (en) Pyrrolidine derivatives having activity at the glyt1 transporter
ZA200711025B (en) N-dihydroxyalkyl-substituted 2-oxoimidazole derivative
PL1779957T3 (pl) Synergistyczny system spawania
EP1870412A4 (en) 2-THIOETHENYLCARBAPENEM DERIVATIVE
GB0511410D0 (en) Benzotrizepinone derivatives
ZA200706577B (en) Dihydroimidazothiazole derivatives
HK1127598A (en) Pyrrolidine derivatives having activity at the glyt1 transporter